References
1 Hanahan, D, Weinberg, RA. The hallmarks of cancer. Cell 2000; 100: 57–70.
2 Land, H, Parada, LF, Weinberg, RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983; 304: 596–602.
3 Lloyd, AC, Obermuller, F, Staddon, S, Barth, CF, McMahon, M,
et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997; 11: 663–677.
4 Fanidi, A, Harrington, EA, Evan, GI. Cooperative interaction between c‐myc and bcl‐2 proto‐oncogenes. Nature 1992; 359: 554–556.
5 Lowe, SW, Cepero, E, Evan, G. Intrinsic tumour suppression. Nature 2004; 432: 307–315.
6 McMurray, HR, Sampson, ER, Compitello, G, Kinsey, C, Newman, L,
et al. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008; 453: 1112.
7 Chuang, HY, Lee, E, Liu, YT, Lee, D, Ideker, T. Network‐based classification of breast cancer metastasis. Mol Syst Biol 2007; 3: 140.
8 Liu, ET, Lemberger, T. Higher order structure in the cancer transcriptome and systems medicine. Mol Syst. Biol 2007; 3: 94.
9 Auffray, C. Protein subnetwork markers improve prediction of cancer outcome. Mol Syst Biol 2007; 3: 141.
10 Neely, KE, Workman, JL. The complexity of chromatin remodeling and its links to cancer. Biochim Biophys Acta 2002; 1603: 19–29.
11 Seligson, DB, Horvath, S, Shi, T, Yu, H, Tze, S,
et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435: 1262.
12 Esteller, M. Cancer epigenomics: DNA methylomes and histone‐modification maps. DNA 2007; 1: E1.
13 Jones, PA. DNA methylation and cancer. Oncogene 2002; 21: 5358–5360.
14 Esteller, M, Fraga, MF, Paz, MF, Campo, E, Colomer, D,
et al. Cancer epigenetics and methylation. Science 2002; 297: 1807–1808.
15 Laird, PW. Cancer epigenetics. Hum. Mol. Genet 2005; 14: 65–76.
16 Tang, Y, Nakada, MT, Kesavan, P, McCabe, F, Millar, H,
et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005; 65: 3193–3199.
17 Condeelis, J, Pollard, JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263–266.
18 Lewis, CE, Pollard, JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605–612.
19 Kalluri, R, Zeisberg, M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392–401.
20 Bhowmick, NA, Neilson, EG, Moses, HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332–337.
21 Sheu, BC, Chang, WC, Cheng, CY, Lin, HH, Chang, DY,
et al. Cytokine regulation networks in the cancer microenvironment. Front Biosci 2008; 13: 6255–6268.
22 De Luca, A, Carotenuto, A, Rachiglio, A, Gallo, M, Maiello, MR,
et al. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 2008; 214: 559–567.
23 Allinen, M, Beroukhim, R, Cai, L, Brennan, C, Lahti‐Domenici, J,
et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17–32.
24 Smallbone, K, Gavaghan, DJ, Gatenby, RA, Maini, PK. The role of acidity in solid tumour growth and invasion. J Theor Biol 2005; 235: 476–484.
25 Smallbone, K, Gatenby, RA, Gillies, RJ, Maini, PK, Gavaghan, DJ. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 2007; 244: 703–713.
26 Gajewski, TF, Meng, Y, Harlin, H. Immune suppression in the tumor microenvironment. J Immunother 2006; 29: 233–240.
27 Gajewski, TF, Meng, Y, Blank, C, Brown, I, Kacha, A,
et al. Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 2006; 213: 131–145.
28 Croci, DO, Zacarías Fluck, MF, Rico, MJ, Matar, P, Rabinovich, GA,
et al. Dynamic cross‐talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 2007; 56: 1687–1700.
29 Laakkonen, P, Waltari, M, Holopainen, T, Takahashi, T, Pytowski, B,
et al. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 2007; 67: 593.
30 Su, JL, Yen, CJ, Chen, PS, Chuang, SE, Hong, CC,
et al. The role of the VEGF‐C/VEGFR‐3 axis in cancer progression. Br J Cancer 2007; 96: 541–545.
31 Hirakawa, S, Brown, LF, Kodama, S, Paavonen, K, Alitalo, K,
et al. VEGF‐C‐induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007; 109: 1010–1017.
32 Taranawski, R, Skladowski, K, Swienrniaka, A, Wygoda, A, Mucha, A. Repopulation of tumour cells during radiotherapy is doubled during treatment gaps. Computational and Mathematical Methods in Medicine 2000; 2: 297–305.
33 Kohandel, M, Sivaloganathan, S, Oza, A. Mathematical modeling of ovarian cancer treatments: sequencing of surgery and chemotherapy. J Theor Biol 2006; 242: 62–68.
34 Verschraegen, C, Vinh‐Hung, V, Cserni, G, Gordon, R, Royce, ME,
et al. Modeling the effect of tumor size in early breast cancer. Ann Surg 2005; 241: 309–318.
35 Ayati, BP, Webb, GF, Anderson, ARA. Computational methods and results for structured multiscale models of tumor invasion. Multiscale Modeling and Simulation 2006; 5: 1–120.
36 Nordling, CO. A new theory on cancer‐inducing mechanism. Br J Cancer 1953; 7: 68–72.
37 Lander, ES, Linton, LM, Birren, B, Nusbaum, C, Zody, MC,
et al. Initial Sequencing and Analysis of the Human Genome 2001; 409: 860–921.
38 Venter, JC, Adams, MD, Myers, EW, Li, PW, Mural, RJ,
et al. The sequence of the human genome. Science 2001; 291: 1304–1351.
39 Parsons, DW, Jones, S, Zhang, X, Lin, JCH, Leary, RJ,
et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807–1812.
40 Sjoblom, T, Jones, S, Wood, LD, Parsons, DW, Lin, J,
et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268–274.
41 Nevins, JR, Potti, A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet 2007; 8: 601–609.
42 Coe, BP, Chari, R, Lockwood, WW, Lam, WL. Evolving strategies for global gene expression analysis of cancer. J Cell Physiol 2008; 217: 590–597.
43 Allison, DB, Cui, X, Page, GP, Sabripour, M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006; 7: 55–65.
44 Mardis, ER. The impact of next‐generation sequencing technology on genetics. Trends Genet 2008; 24: 133–141.
45 Shendure, J, Ji, H. Next‐generation DNA sequencing. Nat Biotechnol 2008; 26: 1135–1145.
46 Gingras, AC, Gstaiger, M, Raught, B, Aebersold, R. Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol 2007; 8: 645–654.
47 Cox, J, Mann, M. Is proteomics the new genomics? Cell 2007; 130: 395–398.
48 Bantscheff, M, Schirle, M, Sweetman, G, Rick, J, Kuster, B. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 2007; 389: 1017–1031.
49 Vienna, A, GmbH, EB, Linz, KHE, Linz, A, Innsbruck, A. Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Electrophoresis 2006; 27: 2659–2675.
50 Edgar, R, Domrachev, M, Lash, AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207–210.
51 Sherlock, G, Hernandez‐Boussard, T, Kasarskis, A, Binkley, G, Matese, JC,
et al. The stanford microarray database. Nucleic Acids Res 2001; 29: 152–155.
52 Perier, RC, Junier, T, Bucher, P. The eukaryotic promoter database EPD. Nucleic Acids Res 1998; 26: 353–357.
53 Zhao, F, Xuan, Z, Liu, L, Zhang, MQ. TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res 2005; 33: D103–D107.
54 Martens, L, Hermjakob, H, Jones, P, Adamski, M, Taylor, C. PRIDE: the proteomics identifications database. Proteomics 2005; 5: 3537–3545.
55 Camon, E, Magrane, M, Barrell, D, Lee, V, Dimmer, E,
et al. The Gene Ontology Annotation (GOA) Database: sharing knowledge in uniprot with gene ontology. Nucleic Acids Res 2004; 32: W313–W317.
56 Apweiler, R, Bairoch, A, Wu, CH, Barker, WC, Boeckmann, B,
et al. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res 2004; 32: D115.
57 Camon, E, Magrane, M, Barrell, D, Binns, D, Fleischmann, W,
et al. The Gene Ontology Annotation (GOA) Project: Implementation of GO in SWISS‐PROT, TrEMBL, and InterPro. Genome Res 2003; 13: 662–672.
58 Flicek, P, Aken, BL, Beal, K, Ballester, B, Caccamo, M,
et al. Ensembl 2008. Nucleic Acids Res 2008; 36(
Database issue): D707–D714.
59 Sterk, P, Kersey, PJ, Apweiler, R. Genome reviews: standardizing content and representation of information about complete genomes. OMICS: A Journal of Integrative Biology 2006; 10: 114–118.
60 Kanehisa, M, Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27–30.
61 Ashburner, M, Ball, CA, Blake, JA, Botstein, D, Butler, H,
et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25–29.
62 Krieger, CJ, Zhang, P, Mueller, LA, Wang, A, Paley, S,
et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res 2004; 34(
Database Issue): D511–D516.
63 Karp, PD, Ouzounis, CA, Moore‐Kochlacs, C, Goldovsky, L, Kaipa, P,
et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res 2005; 33: 6083–6089.
64 DeJongh, M, Formsma, K, Boillot, P, Gould, J, Rycenga, M,
et al. Toward the automated generation of genome‐scale metabolic networks in the SEED. BMC Bioinformatics 2007; 8: 139.
65 Ren, Q, Chen, K, Paulsen, IT. TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res 2006; 35: D274–D279.
66 Le Novère, N, Bornstein, B, Broicher, A, Courtot, M, Donizelli, M,
et al. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res 2006; 34: D689–D691.
67 Sivakumaran, S, Hariharaputran, S, Mishra, J, Bhalla, US. The database of quantitative cellular signaling: management and analysis of chemical kinetic models of signaling networks. Bioinformatics 2003; 19: 408–415.
68 Ji, ZL, Chen, X, Zhen, CJ, Yao, LX, Han, LY,
et al. KDBI: Kinetic Data of Bio‐molecular Interactions database. Nucleic Acids Res 2003; 31: 255–257.
69 Platzer, A, Perco, P, Lukas, A, Mayer, B. Characterization of protein‐interaction networks in tumors. BMC Bioinformatics 2007; 8: 224.
70 Ramani, AK, Bunescu, RC, Mooney, RJ, Marcotte, EM. Consolidating the set of known human protein‐protein interactions in preparation for large‐scale mapping of the human interactome. Genome Biol 2005; 6: R40.
71 Xenarios, I, Salwinski, L, Duan, XJ, Higney, P, Kim, SM,
et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 2002; 30: 303–305.
72 Zanzoni, A, Montecchi‐Palazzi, L, Quondam, M, Ausiello, G, Helmer‐Citterich, M,
et al. MINT: a Molecular INTeraction database. FEBS Lett 2002; 513: 135–140.
73 Pagel, P, Kovac, S, Oesterheld, M, Brauner, B, Dunger‐Kaltenbach, I,
et al. The MIPS mammalian protein‐protein interaction database. Bioinformatics 2005; 21: 832–834.
74 Lloyd, CM, Halstead, MDB, Nielsen, PF. CellML: its future, present and past. Prog Biophys Mol Biol 2004; 85: 433–450.
75 Le Novère, N, Finney, A, Hucka, M, Bhalla, US, Campagne, F,
et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat Biotechnol 2005; 23: 1509–1515.
76 Hucka, M, Finney, A, Sauro, HM, Bolouri, H, Doyle, JC,
et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003; 19: 524–531.
77 Stromback, L, Lambrix, P. Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX. Bioinformatics 2005; 21: 4401–4407.
78 Shannon, PT, Reiss, DJ, Bonneau, R, Baliga, NS. The Gaggle: an open‐source software system for integrating bioinformatics software and data sources. BMC Bioinformatics 2006; 7: 176.
79 Shannon, P, Markiel, A, Ozier, O, Baliga, NS, Wang, JT,
et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.
80 Karolchik, D, Kuhn, RM, Baertsch, R, Barber, GP, Clawson, H,
et al. The UCSC genome browser database: 2008 update. Nucleic Acids Res 2008; 36(
Database issue): D773–D779.
81 Maglott, D, Ostell, J, Pruitt, KD, Tatusova, T. Entrez Gene: gene‐centered information at NCBI. Nucleic Acids Res 2006; 33(
Database issue): D54–D58.
82 Kanehisa, M, Goto, S, Kawashima, S, Nakaya, A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002; 30: 42–46.
83 Cusick, ME, Yu, H, Smolyar, A, Venkatesan, K, Carvunis, AR,
et al. Literature‐Curated Protein Interaction Datasets. Nat Methods 2009; 6: 39–46.
84 Taylor, CF, Field, D, Sansone, SA, Aerts, J, Apweiler, R,
et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 2008; 26: 889–896.
85 Brazma, A, Hingamp, P, Quackenbush, J, Sherlock, G, Spellman, P,
et al. Minimum information about a microarray experiment (MIAME)‐toward standards for microarray data. Nat Genet 2001; 29: 365–371.
86 Taylor, CF, Paton, NW, Lilley, KS, Binz, PA, Julian, RK
Jr,
et al. The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 2007; 25: 887–893.
87 Venkatesan, K, Rual, JF, Vazquez, A, Stelzl, U, Lemmens, I,
et al. An empirical framework for binary interactome mapping. Nature Methods 2008; 6: 83–90.
88 Braun, P, Tasan, M, Dreze, M, Barrios‐Rodiles, M, Lemmens, I,
et al. An experimentally derived confidence score for binary protein‐protein interactions. Nat Methods 2009; 6: 91–97.
89 Quackenbush, J. Microarray analysis and tumor classification. N Engl J Med 2006; 354: 2463–2472.
90 Davis, CA, Gerick, F, Hintermair, V, Friedel, CC, Fundel, K,
et al. Reliable gene signatures for microarray classification: assessment of stability and performance. Bioinformatics 2006; 22: 2356–2363.
91 de Souto, MCP, Costa, IG, de Araujo, DSA, Ludermir, TB, Schliep, A. Clustering cancer gene expression data: a comparative study. BMC Bioinformatics 2008; 9: 497.
92 Alizadeh, AA, Eisen, MB, Davis, RE, Ma, C, Lossos, IS,
et al. Distinct types of diffuse large B‐cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511.
93 Bullinger, L, Dohner, K, Bair, E, Frohling, S, Schlenk, RF,
et al. Use of gene‐expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605–1616.
94 Naderi, A, Teschendorff, AE, Barbosa‐Morais, NL, Pinder, SE, Green, AR,
et al. A gene‐expression signature to predict survival in breast cancer across independent data sets. Oncogene 2006; 26: 1507–1516.
95 Brown, MPS, Grundy, WN, Lin, D, Cristianini, N, Sugnet, CW,
et al. Knowledge‐based analysis of microarray gene expression data by using support vector machines. Proc Nat Acad Sci 2000; 97: 262–267.
96 Khan, J, Wei, JS, Ringnér, M, Saal, LH, Ladanyi, M,
et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001; 7: 673–679.
97 Herrero, J, Valencia, A, Dopazo, J. A hierarchical unsupervised growing neural network for clustering gene expression patterns. Bioinformatics 2001; 17: 126–136.
98 Geman, D. Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 2004; 3.
99 Tan, AC, Naiman, DQ, Xu, L, Winslow, RL, Geman, D. Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics 2005; 21: 3896–3904.
100 Xu, L, Geman, D, Winslow, RL. Large‐scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics 2007; 8: 275.
101 Price, ND, Trent, J, El‐Naggar, AK, Cogdell, D, Taylor, E,
et al. Highly accurate two‐gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Nat Acad Sci 2007; 104: 3414–3419.
102 Chen, HY, Yu, SL, Chen, CH, Chang, GC, Chen, CY,
et al. A five‐gene signature and clinical outcome in non‐small‐cell lung cancer. N Engl J Med 2007; 356: 11–20.
103 Michiels, S, Koscielny, S, Hill, C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365: 488–492.
104 Yeoh, EJ, Ross, ME, Shurtleff, SA, Williams, WK, Patel, D,
et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133–143.
105 Foekens, JA, Atkins, D, Zhang, Y, Sweep, FC, Harbeck, N,
et al. Multicenter validation of a gene expression‐based prognostic signature in lymph node‐negative primary breast cancer. J Clin Oncol 2006; 24: 1665–1671.
106 Ayers, M, Symmans, WF, Stec, J, Damokosh, AI, Clark, E,
et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 2004; 22: 2284–2293.
107 Dressman, HK, Hans, C, Bild, A, Olson, JA, Rosen, E,
et al. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 2006; 12: 819–826.
108 Thuerigen, O, Schneeweiss, A, Toedt, G, Warnat, P, Hahn, M,
et al. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 2006; 24: 1839–1845.
109 Subramanian, A, Kuehn, H, Gould, J, Tamayo, P, Mesirov, JP. GSEA‐P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007; 23: 3251–3253.
110 Kim, SY, Volsky, DJ. PAGE: Parametric Analysis of Gene Set Enrichment. BMC Bioinformatics 2005; 6: 144.
111 Subramanian, A, Tamayo, P, Mootha, VK, Mukherjee, S, Ebert, BL,
et al. Gene set enrichment analysis: a knowledge‐based approach for interpreting genome‐wide expression profiles. Proc Nat Acad Sci 2005; 102: 15545–15550.
112 Rhodes, DR, Chinnaiyan, AM. Integrative analysis of the cancer transcriptome. Nat Genet 2005; 37(
suppl 6): S31–S37.
113 Shen, R, Chinnaiyan, AM, Ghosh, D. Pathway analysis reveals functional convergence of gene expression profiles in breast cancer. BMC Med Genomics 2008; 1: 28.
114 Tomlins, SA, Mehra, R, Rhodes, DR, Cao, X, Wang, L,
et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2006; 39: 41–51.
115 Lee, E, Chuang, HY, Kim, JW, Ideker, T, Lee, D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol 2008; 4: e1000217.
116 Yu, JX, Sieuwerts, AM, Zhang, Y, Martens, JWM, Smid, M,
et al. Pathway analysis of gene signatures predicting metastasis of node‐negative primary breast cancer. BMC Cancer 2007; 7: 182.
117 Smid, M, Wang, Y, Zhang, Y, Sieuwerts, AM, Yu, J,
et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res 2008; 68: 3108–3114.
118 Saal, LH, Johansson, P, Holm, K, Gruvberger‐Saal, SK, She, QB,
et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Nat Acad Sci 2007; 104: 7564–7569.
119 Price, ND, Edelman, LB, Lee, I, Yoo, H, Hwang, D,
et al. %22Systems biology and systems medicine%22. In: Ginsburg, GS, Willard, HF., eds.
Genomic and Personalized Medicine. Amsterdam,
Elservier; 2009; 74–86.
120 Hood, L, Heath, JR, Phelps, ME, Lin, B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004; 306: 640–643.
121 Kitano, H. Systems biology: a brief overview. Science 2002; 295: 1662–1664.
122 Lage, K, Karlberg, EO, Størling, ZM, Ólason, P, Pedersen, AG,
et al. A human phenome‐interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 2007; 25: 309–316.
123 Price, ND, Shmulevich, I. Biochemical and statistical network models for systems biology. Curr Opin Biotechnol 2007; 18: 365–370.
124 Sachs, K, Perez, O, Pe`er, D, Lauffenburger, DA, Nolan, GP. Causal protein‐signaling networks derived from multiparameter single‐cell data. Science 2005; 308: 523–529.
125 Wang, RS, Wang, Y, Zhang, XS, Chen, L. Inferring transcriptional regulatory networks from high‐throughput data. Bioinformatics 2007; 23: 3056–3064.
126 Bansal, M, Gatta, GD, di Bernardo, D. Inference of gene regulatory networks and compound mode of action from time course gene expression profiles. Bioinformatics 2006; 22: 815–822.
127 Bonneau, R. Learning biological networks: from modules to dynamics. Nat Chem Biol 2008; 4: 658–664.
128 Miller‐Jensen, K, Janes, KA, Brugge, JS, Lauffenburger, DA. Common effector processing mediates cell‐specific responses to stimuli. Nature 2007; 448: 604–608.
129 Janes, KA, Albeck, JG, Gaudet, S, Sorger, PK, Lauffenburger, DA,
et al. A systems model of signaling identifies a molecular basis set for cytokine‐induced apoptosis. Science 2005; 310: 1646–1653.
130 Gordus, A, Krall, JA, Beyer, EM, Kaushansky, A, Wolf‐Yadlin, A,
et al. Linear combinations of docking affinities explain quantitative differences in RTK signaling. Mol Syst Biol 2009; 5: 235.
131 Kumar, N, Afeyan, R, Kim, HD, Lauffenburger, DA. Multi‐pathway model enables prediction of kinase inhibitor cross‐talk effects on migration of Her2‐overexpressing mammary epithelial cells. Mol Pharmacol 2008; 73: 1668–1678.
132 Bonneau, R, Reiss, DJ, Shannon, P, Facciotti, M, Hood, L,
et al. The inferelator: an algorithm for learning parsimonious regulatory networks from systems‐biology data sets de novo. Genome Biol 2006; 7: R36.
133 Bonneau, R, Facciotti, MT, Reiss, DJ, Schmid, AK, Pan, M,
et al. A predictive model for transcriptional control of physiology in a free living cell. Cell. 2007; 131: 1354–1365.
134 Bansal, M, Belcastro, V, Ambesi‐Impiombato, A, di Bernardo, D. How to infer gene networks from expression profiles. Mol Syst Biol 2007; 3: 78.
135 Schafer, J, Strimmer, K. An empirical Bayes approach to inferring large‐scale gene association networks. Bioinformatics 2005; 21: 754–764.
136 Basso, K, Margolin, AA, Stolovitzky, G, Klein, U, Dalla‐Favera, R,
et al. Reverse engineering of regulatory networks in human B cells. Nat Genet 2005; 37: 382–390.
137 Hartemink, AJ. Reverse engineering gene regulatory networks. Nat Biotechnol 2005; 23: 554–555.
138 Friedman, N. Inferring cellular networks using probabilistic graphical models. Science 2004; 303: 799–805.
139 Shmulevich, I, Dougherty, ER, Kim, S, Zhang, W. Probabilistic Boolean networks: a rule‐based uncertainty model for gene regulatory networks. Bioinformatics 2002; 18: 261–274.
140 Hashimoto, RF, Kim, S, Shmulevich, I, Zhang, W, Bittner, ML,
et al. Growing genetic regulatory networks from seed genes. Bioinformatics 2004; 20: 1241–1247.
141 Pal, R, Datta, A, Bittner, ML, Dougherty, ER. Intervention in context‐sensitive probabilistic Boolean networks. Bioinformatics 2005; 21: 1211–1218.
142 Soranzo, N, Bianconi, G, Altafini, C. Comparing association network algorithms for reverse engineering of large‐scale gene regulatory networks: synthetic versus real data. Bioinformatics 2007; 23: 1640–1647.
143 Yu, J, Smith, VA, Wang, PP, Hartemink, AJ, Jarvis, ED. Advances to Bayesian network inference for generating causal networks from observational biological data. Bioinformatics 2004; 20: 3594–3603.
144 Camacho, D, Vera, LP, Mendes, P, Laubenbacher, R. Comparison of reverse‐engineering methods using an in silico network. Ann N Y Acad Sci 2007; 1115: 73–89.
145 Margolin, AA, Califano, A. Theory and limitations of genetic network inference from microarray data. Ann N Y Acad Sci 2007; 1115: 51–72.
146 Feist, AM, Herrgard, MJ, Thiele, I, Reed, JL, Palsson, B. Reconstruction of biochemical networks in microbial organisms. Nat Rev Microbiol 2009; 7: 129–143.
147 Francke, C, Siezen, RJ, Teusink, B. Reconstructing the metabolic network of a bacterium from its genome. Trends Microbiol 2005; 13: 550–558.
148 Reed, JL, Famili, I, Thiele, I, Palsson, BO. Towards multidimensional genome annotation. Nat Rev Genet 2006; 7: 130–141.
149 Feist, AM, Henry, CS, Reed, JL, Krummenacker, M, Joyce, AR,
et al. A genome‐scale metabolic reconstruction for
Escherichia coli K‐12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 2007; 3: 121.
150 Feist, AM, Scholten, JCM, Palsson, B, Brockman, FJ, Ideker, T. Modeling methanogenesis with a genome‐scale metabolic reconstruction of Methanosarcina barkeri. Mol Syst Biol 2006; 2:(2006.0004).
151 Herrgard, MJ, Swainston, N, Dobson, P, Dunn, WB, Arga, KY,
et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol 2008; 26: 1155–1160.
152 Chavali, AK, Whittemore, JD, Eddy, JA, Williams, KT, Papin, JA. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol 2008; 4: 177.
153 Duarte, NC, Becker, SA, Jamshidi, N, Thiele, I, Mo, ML,
et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Nat Acad Sci 2007; 104: 1777–1782.
154 Ma, H, Sorokin, A, Mazein, A, Selkov, A, Selkov, E,
et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 2007; 3: 135.
155 Hoffmann, A, Levchenko, A, Scott, ML, Baltimore, D. The Ikappa B‐NF‐kappa B signaling module: temporal control and selective gene activation. Science 2002; 298: 1241–1245.
156 Papin, JA, Hunter, T, Palsson, BO, Subramaniam, S. Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol 2005; 6: 99–111.
157 Papin, JA, Palsson, BO. Topological analysis of mass‐balanced signaling networks: a framework to obtain network properties including crosstalk. J Theor Biol 2004; 227: 283–297.
158 Gianchandani, EP, Papin, JA, Price, ND, Joyce, AR, Palsson, BO,
et al. Matrix formalism to describe functional states of transcriptional regulatory systems. PLoS Comput Biol 2006; 2: e101.
159 Covert, MW, Knight, EM, Reed, JL, Herrgard, MJ, Palsson, BO. Integrating high‐throughput and computational data elucidates bacterial networks. Nature 2004; 429: 92–96.
160 Price, ND, Reed, JL, Palsson, BO. Genome‐scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol 2004; 2: 886–897.
161 Vo, TD, Greenberg, HJ, Palsson, BO. Reconstruction and functional characterization of the human mitochondrial metabolic network based on proteomic and biochemical data. J Biol Chem 2004; 279: 39532–39540.
162 Thiele, I, Price, ND, Vo, TD, Palsson, BO. Candidate metabolic network states in human mitochondria: impact of diabetes, ischemia, and diet. J Biol Chem 2005; 280: 11683–11695.
163 Price, ND, Schellenberger, J, Palsson, BO. Uniform sampling of steady‐state flux spaces: means to design experiments and to interpret enzymopathies. Biophys J 2004; 87: 2172–2186.
164 Papin, JA, Palsson, BO. The JAK‐STAT signaling network in the human B‐cell: an extreme signaling pathway analysis. Biophys J 2004; 87: 37–46.
165 Lee, DS, Park, J, Kay, KA, Christakis, NA, Oltvai, ZN,
et al. The implications of human metabolic network topology for disease comorbidity. Proc Nat Acad Sci 2008; 105: 9880–9885.
166 Ma, H, Goryanin, I. Human metabolic network reconstruction and its impact on drug discovery and development. Drug Discov Today 2008; 13: 402–408.
167 Shlomi, T, Cabili, MN, Herrgård, MJ, Palsson, B, Ruppin, E. Network‐based prediction of human tissue‐specific metabolism. Nat Biotechnol 2008; 26: 1003–1010.
168 Robey, IF, Lien, AD, Welsh, SJ, Baggett, BK, Gillies, RJ. Hypoxia‐inducible factor‐1a and the glycolytic phenotype in tumors. Neoplasia 2005; 7: 324–330.
169 Esteban, MA, Maxwell, PH. HIF, a missing link between metabolism and cancer. Nat Med 2005; 11: 1047–1048.
170 Kroemer, G, Pouyssegur, J. Tumor cell metabolism: cancer`s Achilles` heel. Cancer Cell 2008; 13: 472–482.
171 Hsu, PP, Sabatini, DM. Cancer cell metabolism: warburg and beyond. Cell 2008; 134: 703–707.
172 Galmarini, CM, Popowycz, F, Joseph, B. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. Curr Med Chem 2008; 15: 1072–1082.
173 Serkova, NJ, Spratlin, JL, Eckhardt, SG. NMR‐based metabolomics: translational application and treatment of cancer. Curr Opin Mol Ther 2007; 9: 572–585.
174 Robak, T, Lech‐Maranda, E, Korycka, A, Robak, E. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. Curr Med Chem 2006; 13: 3165–3189.
175 Werner, SL, Barken, D, Hoffmann, A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 2005; 309: 1857–1861.
176 Segre, D, Zucker, J, Katz, J, Lin, X, D`Haeseleer, P,
et al. From annotated genomes to metabolic flux models and kinetic parameter fitting. OMICS 2003; 7: 301–316.
177 Aldridge, BB, Burke, JM, Lauffenburger, DA, Sorger, PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 2006; 8: 1195–1203.
178 Kholodenko, BN. Cell‐signalling dynamics in time and space. Nat Rev Mol Cell Biol 2006; 7: 165–176.
179 Covert, MW, Leung, TH, Gaston, JE, Baltimore, D. Achieving stability of lipopolysaccharide‐induced NF‐kappaB activation. Science 2005; 309: 1854–1857.
180 Geva‐Zatorsky, N, Rosenfeld, N, Itzkovitz, S, Milo, R, Sigal, A,
et al. Oscillations and variability in the p53 system. Mol Syst Biol 2006; 2: 2006.0033.
181 Ma, L, Wagner, J, Rice, JJ, Hu, W, Levine, AJ,
et al. A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci USA 2005; 102: 14266–14271.
182 Hennessy, BT, Smith, DL, Ram, PT, Lu, Y, Mills, GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988–1004.
183 Asthagiri, AR, Lauffenburger, DA. A computational study of feedback effects on signal dynamics in a mitogen‐activated protein kinase (MAPK) pathway model. Biotechnol Prog 2001; 17: 227–239.
184 Brightman, FA, Fell, DA. Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 2000; 482: 169–174.
185 Schoeberl, B, Eichler‐Jonsson, C, Gilles, ED, Muller, G. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 2002; 20: 370–375.
186 Christopher, R, Dhiman, A, Fox, J, Gendelman, R, Haberitcher, T,
et al. Data‐driven computer simulation of human cancer cell. Ann N Y Acad Sci 2004; 1020: 132–153.
187 Li, H, Fan, X, Houghton, J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007; 101: 805–815.
188 Bellomo, N, Preziosi, L. Modelling and mathematical problems related to tumor evolution and its interaction with the immune system. Math Comput Model 2000; 32: 413–452.
189 Araujo, RP, McElwain, DL. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol 2004; 66: 1039–1091.
190 Araujo, RP, McElwain, DLS. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol 2004; 66: 1039–1091.
191 Quaranta, V, Rejniak, KA, Gerlee, P, Anderson, AR. Invasion emerges from cancer cell adaptation to competitive microenvironments: quantitative predictions from multiscale mathematical models. Semin Cancer Biol 2008; 18: 338–348.
192 Alarcón, T, Byrne, HM, Maini, PK. A mathematical model of the effects of hypoxia on the cell‐cycle of normal and cancer cells. J Theor Biol 2004; 229: 395–411.
193 Ambrosi, D, Mollica, F. The role of stress in the growth of a multicell spheroid. J Math Biol 2004; 48: 477–499.
194 Anderson, ARA. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005; 22: 163–186.
195 Johnston, MD, Edwards, CM, Bodmer, WF, Maini, PK, Chapman, SJ. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc Nat Acad Sci 2007; 104: 4008.
196 d`Onofrio, A, Tomlinson, IPM. A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J Theor Biol 2007; 244: 367–374.
197 Byrne, H, Preziosi, L. Modelling solid tumour growth using the theory of mixtures. Math Med Biol 2003; 20: 341–366.
198 Breward, CJW, Byrne, HM, Lewis, CE. The role of cell‐cell interactions in a two‐phase model for avascular tumour growth. J Math Biol 2002; 45: 125–152.
199 Macklin, P, Lowengrub, J. Nonlinear simulation of the effect of microenvironment on tumor growth. J Theor Biol 2007; 245: 677–704.
200 Alarcon, T, Byrne, HM, Maini, PK. A multiple scale model for tumor growth. Multiscale Model Simul 2005; 3: 440–475.
201 Spencer, SL, Berryman, MJ, García, JA, Abbott, D. An ordinary differential equation model for the multistep transformation to cancer. J Theor Biol 2004; 231: 515–524.
202 Baum, M, Chaplain, MAJ, Anderson, ARA, Douek, M, Vaidya, JS. Does breast cancer exist in a state of chaos? Eur J Cancer 1999; 35: 886–891.
203 Rew, DA. Tumour biology, chaos and non‐linear dynamics. Eur J Surg Oncol 1999; 25: 86–89.
204 Deisboeck, TS, Yoon, J, Costa, J. In silico cancer modeling: is it ready for prime time? Nat Clin Pract Oncol 2008; 6: 34–42.
205 Mansury, Y, Kimura, M, Lobo, J, Deisboeck, TS. Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent‐based spatial agglomeration model. J Theor Biol 2002; 219: 343–370.
206 Little, MP, Vineis, P, Li, G. A stochastic carcinogenesis model incorporating multiple types of genomic instability fitted to colon cancer data. J Theor Biol 2008; 254: 229–238.
207 Dingli, D, Traulsen, A, Pacheco, JM. Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 2007; 6: 461–466.
208 Ostby, I, Oyehaug, L, Steen, HB. A stochastic model of cancer initiation including a bystander effect. J Theor Biol 2006; 241: 751–764.
209 Kansal, AR, Torquato, S, Harsh Iv, GR, Chiocca, EA, Deisboeck, TS. Simulated brain tumor growth dynamics using a three‐dimensional cellular automaton. J Theor Biol 2000; 203: 367–382.
210 Mallet, DG, De Pillis, LG. A cellular automata model of tumor–immune system interactions. J Theor Biol 2006; 239: 334–350.
211 Alarcón, T, Byrne, HM, Maini, PK. A cellular automaton model for tumour growth in inhomogeneous environment. J Theor Biol 2003; 225: 257–274.
212 Bauer, AL, Jackson, TL, Jiang, Y. A cell‐based model exhibiting branching and anastomosis during tumor‐induced angiogenesis. Biophys J 2007; 92: 3105–3121.
213 Patel, AA, Gawlinski, ET, Lemieux, SK, Gatenby, RA. A cellular automaton model of early tumor growth and invasion: the effects of native tissue vascularity and increased anaerobic tumor metabolism. J Theor Biol 2001; 213: 315–331.
214 Mansury, Y, Deisboeck, TS. The impact of “search precision” in an agent‐based tumor model. J Theor Biol 2003; 224: 325–337.
215 McDougall, SR, Anderson, ARA, Chaplain, MAJ. Mathematical modelling of dynamic adaptive tumour‐induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol 2006; 241: 564–589.
216 Anderson, AR. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005; 22: 163–186.
217 Zhang, L, Athale, CA, Deisboeck, TS. Development of a three‐dimensional multiscale agent‐based tumor model: simulating gene‐protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor. Biol 2007; 244: 96–107.
218 Anderson, AR, Weaver, AM, Cummings, PT, Quaranta, V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006; 127: 905–915.
219 Ohno, R, Nakamura, Y. Prediction of response to imatinib by cDNA microarray analysis. Semin Hematol 2003; 42–49.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
